By Nicholas G. Miller
Shares of Chemours fell after the company reported a wider fourth-quarter loss, partially due to challenging market conditions.
The stock dropped 9.9% to $18.39 in premarket trading. As of Thursday's close, it was up 73% this year.
The company reported a loss of 31 cents a share, compared with 8 cents a share the year prior.
Adjusted profit came in at 5 cents a share, below the 7 cents a share that analysts were expecting, according to FactSet.
Chief Executive Denise Dignam said short-term end-market headwinds in its advanced performance materials business led it to incur a "sizable non-cash inventory charge and unfavorable product mix."
Macroeconomic conditions have remained "tepid," but the company expects significant cash generation in 2026, Dignam said.
Write to Nicholas G. Miller at nicholas.miller@wsj.com.
(END) Dow Jones Newswires
February 20, 2026 07:34 ET (12:34 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.